Beijing Tongren Eye Center, Beijing Tongren Hospital.
National Key Discipline of Pediatrics, Ministry of Education, Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University.
J Glaucoma. 2019 Jan;28(1):1-6. doi: 10.1097/IJG.0000000000001116.
To evaluate the effectiveness of microcatheter-assisted trabeculotomy (MAT) to treat primary congenital glaucoma after failed previous glaucoma surgeries.
Retrospective, noncomparative, interventional case series conducted at Beijing Tongren Eye Center, China. Outcome measures were compared between 3 groups: successful and complete (≥330 degrees) MAT; successful and partial (<330 degrees) MAT; or cases converted to traditional trabeculotomy when the Schlemm's canal could not be catheterized >180 degrees. Success was defined as final intraocular pressure ≤21 mm Hg, with (qualified success) or without (complete success) glaucoma medications.
In total, 74 eyes of 63 consecutive patients were included. MAT was performed in 50 eyes (67.6%). Postoperative intraocular pressure and number of glaucoma drops (17.7±8.6 mm Hg, 0.6±1.2 medications) was significantly less than the preoperative values (35.3±7.2 mm Hg, 2.7±0.8 medications; P<0.001). Cumulative probabilities of qualified and complete success were 84.0% and 80.0% at 3-year follow-up with no difference between complete and partial trabeculotomies. MAT was not successfully performed in 24 eyes (32.4%), requiring conversion to traditional trabeculotomy and associated with greater incidence of previous surgeries (P<0.001), earlier age of disease onset (P=0.024) and worse corneal transparency (P=0.010). Cumulative probabilities of qualified and complete success were 37.0% and 29.2% at 3-year follow-up.
Both complete and partial MAT achieved significant pressure reduction in cases of primary congenital glaucoma with previous failed glaucoma surgeries in intermediate term.
评估微导管辅助小梁切开术(MAT)治疗既往青光眼手术后失败的原发性先天性青光眼的有效性。
在中国北京同仁眼科中心进行回顾性、非对照、干预性病例系列研究。将 3 组的结果进行比较:成功且完全(≥330 度)MAT;成功且部分(<330 度)MAT;或当 Schlemm 管不能导管化>180 度时转换为传统小梁切开术的病例。成功定义为最终眼压≤21mmHg,有(合格成功)或没有(完全成功)青光眼药物。
共有 63 例连续患者的 74 只眼纳入研究。50 只眼(67.6%)行 MAT。术后眼压和青光眼滴剂数量(17.7±8.6mmHg,0.6±1.2 种药物)明显低于术前值(35.3±7.2mmHg,2.7±0.8 种药物;P<0.001)。3 年随访时,合格和完全成功的累积概率分别为 84.0%和 80.0%,完全和部分小梁切开术之间无差异。24 只眼(32.4%)未成功行 MAT,需要转换为传统小梁切开术,且与既往手术次数更多(P<0.001)、疾病发病年龄更早(P=0.024)和角膜透明度更差(P=0.010)相关。3 年随访时,合格和完全成功的累积概率分别为 37.0%和 29.2%。
既往青光眼手术失败的原发性先天性青光眼,MAT 可在中期获得显著的降压效果,且完全和部分 MAT 均有效。